Our Diagnostics businesses are industry leaders that improve diagnostic confidence around the world—from local clinics and family physicians’ offices to top trauma, cancer, and critical care centers. Operating across six continents, we harness digital data to enable precision diagnostics and improve health outcomes.
Our Diagnostics businesses
Our businesses build upon a foundation of quality and efficiency to give patients an experience that involves world-class diagnostic capabilities and unmatched dependability. With a data insight foundation for established use-cases, we’re a global leader in accelerating innovation. Our team of over 23,000 associates around the globe contribute to advancing life-changing science and technology daily, so life-saving diagnostic health care is accessible to patients around the world.
Beckman Coulter develops, manufactures and markets innovative products to simplify and automate complex biomedical testing.
Cepheid is dedicated to improving healthcare by developing, manufacturing and marketing accurate yet easy-to-use molecular systems and tests.
HemoCue is a global leader in a field of diagnostics known as near-patient, or point‐of‐care, testing.
Leica Biosystems is a cancer diagnostics company and a global leader in workflow solutions.
Mammotome is the global leader in breast biopsy markers, offering clinicians customized solutions for every breast biopsy need.
Every day, half a million blood samples are tested around the world using Radiometer equipment.